NCT06756620View on ClinicalTrials.gov

Investigation of the Etiology of Hypertension and Endothelial Damage in Patients With Cytochrome P450 Oxidoreductase Deficiency

CompletedOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

December 24, 2024

Primary Completion Date

August 12, 2025

Study Completion Date

August 12, 2025

Conditions

Cytochrome P450 Oxidoreductase DeficiencyHypertensionEndothelial DysfunctionCongenital Adrenal Hyperplasia

Trial Locations (1)

34093

Istanbul University, Istanbul

All Listed Sponsors

collaborator

The Scientific and Technological Research Council of Turkey

OTHER

collaborator

Istanbul University

OTHER

lead

Ozge Bayrak Demirel

OTHER

NCT06756620 - Investigation of the Etiology of Hypertension and Endothelial Damage in Patients With Cytochrome P450 Oxidoreductase Deficiency | Biotech Hunter | Biotech Hunter